Sanofi has added to its vaccine pipeline with an agreement to acquire Austria's Origimm Biotechnology and its vaccine-based immunotherapy for people with acne.
Sienna Biopharmaceuticals said on Monday (30th July) that two pivotal trials of its main experimental acne treatment did not achieve their primary endpoints, sending its shares tumbling by
Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved